Literature DB >> 1666627

hu-PBL-SCID mice: a model for human immune function, AIDS, and lymphomagenesis.

B E Torbett1, G Picchio, D E Mosier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1666627     DOI： 10.1111/j.1600-065x.1991.tb00620.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  29 in total

1.  The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.

Authors:  R Longnecker; C L Miller; X Q Miao; A Marchini; E Kieff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 2.  Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.

Authors:  Paul W Denton; J Victor Garcia
Journal:  Trends Microbiol       Date:  2012-04-12       Impact factor: 17.079

3.  Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.

Authors:  Jinyun Yuan; Jianbin Wang; Karen Crain; Colleen Fearns; Kenneth A Kim; Kevin L Hua; Philip D Gregory; Michael C Holmes; Bruce E Torbett
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

4.  Human immune system mice: current potential and limitations for translational research on human antibody responses.

Authors:  Raja Vuyyuru; John Patton; Tim Manser
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

5.  Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals.

Authors:  C Zhang; Y Cui; S Houston; L J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

6.  Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease.

Authors:  Steve Pino; Michael A Brehm; Laurence Covassin-Barberis; Marie King; Bruce Gott; Thomas H Chase; Jennifer Wagner; Lisa Burzenski; Oded Foreman; Dale L Greiner; Leonard D Shultz
Journal:  Methods Mol Biol       Date:  2010

Review 7.  In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.

Authors:  T S Barry; B F Haynes
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

8.  Immunotherapy of human colon cancer by antibody-targeted superantigens.

Authors:  M Dohlsten; P A Lando; P Björk; L Abrahmsén; L Ohlsson; P Lind; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

9.  Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.

Authors:  D L Greiner; L D Shultz; J Yates; M C Appel; G Perdrizet; R M Hesselton; I Schweitzer; W G Beamer; K L Shultz; S C Pelsue
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

Review 10.  Use of humanized severe combined immunodeficient mice for human vaccine development.

Authors:  Gloria C Koo; Aisha Hasan; Richard J O'Reilly
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.